跳至主要内容
临床试验/IRCT201205159753N1
IRCT201205159753N1已完成未知

Effects of a vitamin D analog on glycemic control and immune response in type 1 diabetic children

Endocrinology & Metabolism Research Institute, Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
8 years 至 18 years(—)
性别
All

入选标准

  • Age 8-18 years; Consecutively diagnosed as having T1DM according to the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus criteria; Without DKA; Duration of clinical disease (since the beginning of insulin therapy) less than 8 weeks; Without any medical co-morbidities or any other major chronic disease; Being on a stable diabetic diet therapy at least since 1 week ago
  • Exclusion criteria: Cholecalciferol, calcium, multi-vitamin or mineral supplementation during the previous 3 months; Consuming some vitamin D-fortified foods; Hypercalcemia defined as total serum calcium higher than 10.8 mg/dl, at baseline or during follow-up.

排除标准

  • 未提供

研究者

发起方
Endocrinology & Metabolism Research Institute, Tehran University of Medical Sciences

相似试验